These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3047526)

  • 1. Comparison of two equine oestrogen-dydrogesterone regimens in the climacteric.
    Caudron J; Hendrickx B
    Maturitas; 1988 Jul; 10(2):133-41. PubMed ID: 3047526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone.
    Ferenczy A; Gelfand MM
    Maturitas; 1997 Apr; 26(3):219-26. PubMed ID: 9147354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the withdrawal bleeding pattern and endometrial histology during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women: a 2 year prospective study.
    van der Mooren MJ; Hanselaar AG; Borm GF; Rolland R
    Maturitas; 1994 Dec; 20(2-3):175-80. PubMed ID: 7715470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
    Grisar J; Travica S; Metka M; Pietschmann P
    Wien Klin Wochenschr; 1999 Dec; 111(24):1035-43. PubMed ID: 10677891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D; Conradt C; Jesinger D; Bakowski M
    Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate metabolism during hormonal substitution therapy.
    De Cleyn K; Buytaert P; Coppens M
    Maturitas; 1989 Sep; 11(3):235-42. PubMed ID: 2687646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.
    Foster RH; Balfour JA
    Drugs Aging; 1997 Oct; 11(4):309-32. PubMed ID: 9342560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of lipoproteins of two progestogens used during cyclical hormone replacement therapy.
    Fletcher CD; Farish E; Dagen MM; Hart DM
    Maturitas; 1987 Nov; 9(3):253-8. PubMed ID: 3431476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone.
    Siddle NC; Fraser D; Whitehead MI; Jesinger DK; Endacott J; Prescott P; Pryse-Davies J
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1101-7. PubMed ID: 2177648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2-year study on the beneficial effects of 17 beta-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone.
    van der Mooren MJ; Demacker PN; Thomas CM; Borm GF; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1993 Dec; 52(2):117-23. PubMed ID: 8157140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial.
    Xue W; Deng Y; Wang YF; Sun AJ
    Chin Med J (Engl); 2016 Dec; 129(23):2773-2779. PubMed ID: 27900987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood lipids and the clinical state of hormone-treated women during menopause].
    Dominiczak-Gawrońska M
    Ann Acad Med Stetin; 1989; 35():145-66. PubMed ID: 2484147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17beta-oestradiol and 2.5mg dydrogesterone: protection of the endometrium and amenorrhoea rate.
    Bergeron C; Nogales FF; Rechberger T; Tatarchjuk T; Zipfel L
    Maturitas; 2010 Jun; 66(2):201-5. PubMed ID: 20378287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy.
    Casper RF; Chapdelaine A
    Am J Obstet Gynecol; 1993 Apr; 168(4):1188-94; discussion 1194-6. PubMed ID: 8475965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study to evaluate a new regimen to treat climacteric complaints with cyclic combined oestradiol valerate/medroxyprogesterone acetate.
    Hellberg D; Nilsson S
    Maturitas; 1987 Apr; 9(1):103-7. PubMed ID: 2955203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms.
    Høvik P; Sundsbak HP; Gaasemyr M; Sandvik L
    Maturitas; 1989 Mar; 11(1):75-82. PubMed ID: 2498620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine estrogen-dydrogesterone therapy in the management of postmenopausal women.
    De Cleyn K; Buytaert P; Delbeke L; Gerris J
    Eur J Obstet Gynecol Reprod Biol; 1986 Nov; 23(3-4):201-9. PubMed ID: 3817262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with withdrawal bleeding after administration of oral dydrogesterone or medroxyprogesterone acetate in women with secondary amenorrhea.
    Battino S; Ben-Ami M; Geslevich Y; Weiner E; Shalev E
    Gynecol Obstet Invest; 1996; 42(2):113-6. PubMed ID: 8878716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-ranging study of the use of cyclical dydrogesterone with continuous 17 beta oestradiol.
    Burch DJ; Spowart KJ; Jesinger DK; Randall S; Smith SK
    Br J Obstet Gynaecol; 1995 Mar; 102(3):243-8. PubMed ID: 7794851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.